Not sure relaxin...,
Appears to be a seller(s) since breastcancer 1b results.
Coincidently, the selling seems to have continued despite the pre-release of the AML 1b results??
And has continued to erode the SP since.
Small parcels (except for the approximately 2mil by a substantial holder asx announcement).
Set and forget with small parcel accumulation as funds come avail(IMO).
Willing to wait for ovarian cancer 1b results, and more specifically, breastcancer phase 2 interim late 2018/early 2019, respectively.
That said, the above paragraph possibly give a clue as to the haste of selling below value, added by the perceived delay in the ptx-100 trial now scheduled to commence early 2019.
Very little resistance till sub 6 cents, selling would be frustrating at these levels and below.
Not sure if any of the above rambling has helped.
